Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
aIIV-B stands for "adjuvanted inactivated influenza vaccine, quadrivalent, B strain." It is not an individual pharmaceutical drug but rather refers to a specific formulation of the influenza vaccine. The "a" denotes that it is adjuvanted (contains an immune-boosting substance), "IIV" means inactivated influenza vaccine (the virus is killed and cannot cause disease), and "B" indicates that it targets the Influenza B virus strains. This type of vaccine is used primarily for seasonal flu prevention, especially in populations at higher risk such as older adults. The adjuvant enhances the immune response to the viral antigens present in the vaccine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aIIV-B.